Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ray Borrow

Showing results (231-240 of 403) with videos related to

Pageof 41
Sort By:
BMJ Open|March 11, 2019
Serological surveillance of influenza in an English sentinel network: pilot study protocolSimon de Lusignan, Ray Borrow, Manasa Tripathy, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 23, 2026
First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023Kirsty Foster, Emma J Heymer, Helen Campbell, et al.
Vaccine|December 29, 2016
Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancyDavid Pace, Ameneh Khatami, Simon Attard-Montalto, et al.
The Journal of Infectious Diseases|May 24, 2019
Potentiation of Phase Variation in Multiple Outer-Membrane Proteins During Spread of the Hyperinvasive Neisseria meningitidis Serogroup W ST-11 LineageLuke R Green, Neelam Dave, Adeolu B Adewoye, et al.
Lancet (London, England)|January 20, 2017
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort studySydel R Parikh, Nick J Andrews, Kazim Beebeejaun, et al.
Travel Medicine and Infectious Disease|May 13, 2023
Carriage of Neisseria meningitidis among travelers attending the Hajj pilgrimage, circulating serogroups, sequence types and antimicrobial susceptibility: A multinational longitudinal cohort studySaber Yezli, Yara Yassin, Abdulaziz Mushi, et al.
The Journal of Infection|March 31, 2016
Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distributionStephen A Clark, Aiswarya Lekshmi, Jay Lucidarme, et al.
Clinical and Vaccine Immunology : CVI|August 28, 2009
Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, NepalAnoop S Pulickal, Samir Gautam, Elizabeth A Clutterbuck, et al.
Human Vaccines|October 9, 2007
Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesiclesMichelle Finney, Thomas Vaughan, Stephen Taylor, et al.
Clinical and Vaccine Immunology : CVI|March 28, 2014
Development and use of a serum bactericidal assay using pooled human complement to assess responses to a meningococcal group A conjugate vaccine in African toddlersMargaret C Bash, Freyja Lynn, Brian Mocca, et al.
Pageof 41

Showing results (231-240 of 403) with videos related to

Sort By:
Pageof 41
BMJ Open|March 11, 2019
Serological surveillance of influenza in an English sentinel network: pilot study protocolSimon de Lusignan, Ray Borrow, Manasa Tripathy, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|January 23, 2026
First use of Trumenba (MenB-fHbp) vaccine to control a nursery outbreak of serogroup B invasive meningococcal disease involving children previously immunised with Bexsero (4CMenB), England, November 2023Kirsty Foster, Emma J Heymer, Helen Campbell, et al.
Vaccine|December 29, 2016
Use of a booster dose of capsular group C meningococcal glycoconjugate vaccine to demonstrate immunologic memory in children primed with one or two vaccine doses in infancyDavid Pace, Ameneh Khatami, Simon Attard-Montalto, et al.
The Journal of Infectious Diseases|May 24, 2019
Potentiation of Phase Variation in Multiple Outer-Membrane Proteins During Spread of the Hyperinvasive Neisseria meningitidis Serogroup W ST-11 LineageLuke R Green, Neelam Dave, Adeolu B Adewoye, et al.
Lancet (London, England)|January 20, 2017
Effectiveness and impact of a reduced infant schedule of 4CMenB vaccine against group B meningococcal disease in England: a national observational cohort studySydel R Parikh, Nick J Andrews, Kazim Beebeejaun, et al.
Travel Medicine and Infectious Disease|May 13, 2023
Carriage of Neisseria meningitidis among travelers attending the Hajj pilgrimage, circulating serogroups, sequence types and antimicrobial susceptibility: A multinational longitudinal cohort studySaber Yezli, Yara Yassin, Abdulaziz Mushi, et al.
The Journal of Infection|March 31, 2016
Differences between culture & non-culture confirmed invasive meningococci with a focus on factor H-binding protein distributionStephen A Clark, Aiswarya Lekshmi, Jay Lucidarme, et al.
Clinical and Vaccine Immunology : CVI|August 28, 2009
Kinetics of the natural, humoral immune response to Salmonella enterica serovar Typhi in Kathmandu, NepalAnoop S Pulickal, Samir Gautam, Elizabeth A Clutterbuck, et al.
Human Vaccines|October 9, 2007
Characterization of the key antigenic components and pre-clinical immune responses to a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesiclesMichelle Finney, Thomas Vaughan, Stephen Taylor, et al.
Clinical and Vaccine Immunology : CVI|March 28, 2014
Development and use of a serum bactericidal assay using pooled human complement to assess responses to a meningococcal group A conjugate vaccine in African toddlersMargaret C Bash, Freyja Lynn, Brian Mocca, et al.
Pageof 41